Nudge Lebanon. 3rd Floor, GS Building, Sit Nasab Street
Beirut, Lebanon
NCT Number: NCT04324723
The study had two stages. Stage 1 involved an opportunistic screening for hypertension conducted at the 2018 Beirut Marathon. During stage 1, participants whose measurements indicated hypertension were invited to take part in a RCT (randomized controlled trial). Stage 2 involved a RCT to evaluate the effectiveness of a behavioural intervention to increase the proportion of participants who sought further medical attention. The research team hypothesised that the intervention would increase the proportion of participants who sought further medical attention compared to a control group that did not receive the intervention.
This is a retrospective registration specifically focused on the RCT component of this study. The study was conducted by Nudge Lebanon in partnership with B4- development (formerly known as QBIU) and SmartScience. The RCT was not pre-registered because the collaborators were unaware that pre-registration would be necessary. The collaborators asked the University of Warwick to re-analyse and write the project up for publication after the study was complete. The University of Warwick is now seeking to retrospectively register the trial before submitting to an academic journal. The fact that this trial is retrospectively registered will be plainly stated in the manuscript and all analyses will be presented as exploratory.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Beirut, Lebanon
This study had two stages. Stage 1 involved an opportunistic screening and Stage 2 involved in RCT. This registration focuses on the RCT but both stages are described here.
Stage 1. The opportunistic screening for hypertension was conducted around the 2018 Beirut Marathon. Screening tents were set up at the marathon village during the four days leading up to the marathon (7-10 November), where runners collected necessary materials for the run and could take up the screening. An additional two tents were set up during the marathon day were spectators could take part. Participants indicated their consent for the screening before taking part. During their participation they completed surveys about their demographics and health information (including whether they were hypertensive). After they completed the survey, nurses and trained team members measured their blood pressure using calibrated equipment. Those participants whose measurements indicated hypertension were invited to participate in the RCT.
Stage 2. For the RCT participants were randomly assigned to either a intervention or control group in a 1:1 fashion. Participants in the intervention group were sent a WhatsApp message 25 days after the marathon reminding them to seek help for their hypertensive condition. Participants in the control group were not sent this message. Then one month later the researchers called all these participants to ask wither they sought further medical attention. The main outcome was whether participants self-reported seeking further medical attention.
The research objectives were as follows:
Stage 1 screening: Evaluate if the opportunistic screening increased people's awareness of their hypertensive condition.
Stage 2 RCT: Evaluate if the intervention increased the proportion of participants who sought further medical attention.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The experimentally evaluated part of the intervention is a WhatsApp message.
The message translated from Arabic to English appears below. "Dear [First name], Your BP reading during Beirut Marathon was [reading]. This indicates that you have elevated blood pressure. You should seek medical attention at your earliest convenience. Your wellbeing matters to us. Nudge Lebanon team"
Time frame: Response taken 56 days after the opportunistic screening (1 = Yes-sought further medical attention, 0 = No)
If participants tell the researcher that they sought further medical attention via a phone call they received approximately 1 month after the WhatsApp messages were sent to participants.
Time frame: A survey response taken at the opportunistic screening.(1 = Yes-experiencing hypertension, 0 = No)
Whether participant says in a pre-intervention survey that they are experiencing hypertension
Time frame: A survey response taken at the opportunistic screening.(1 = Yes-experiencing diabetes, 0 = No)
Whether participant says in a pre-intervention survey that they are experiencing diabetes
Time frame: A survey response taken at the opportunistic screening.(1 = Yes-experiencing high cholesterol, 0 = No)
Whether participant says in a pre-intervention survey that they are experiencing high cholesterol.
Time frame: An objective measure taken at the opportunistic screening using an Omron 5 Series BP742N blood pressure monitor
Objectively measured at screening event
Time frame: An objective measure taken at the opportunistic screening using an Omron 5 Series BP742N blood pressure monitor
Objectively measured at screening event
Time frame: An objective measure taken at the opportunistic screening using an Omron 5 Series BP742N blood pressure monitor
Objectively measured at screening event
Time frame: A survey response taken at the opportunistic screening.
Year indicated in pre-intervention survey
Time frame: A survey response taken at the opportunistic screening.
Height indicated in pre-intervention survey
Time frame: A survey response taken at the opportunistic screening.
Weight indicated in pre-intervention survey
Time frame: A survey response taken at the opportunistic screening.
Knowledge of family history indicated in pre-intervention survey
Time frame: A survey response taken at the opportunistic screening.
Knowledge of blood pressure health problems indicated in pre-intervention survey
Time frame: A survey response taken at the opportunistic screening.
Knowledge of diagnostic thresholds indicated in pre-intervention survey
Time frame: A survey response taken at the opportunistic screening. (1 = Yes-blood pressure checking, 0 = No)
Self-reported blood pressure checking
Time frame: A survey response taken at the opportunistic screening. (1 = Yes-cholesterol checking, 0 = No)
Self-reported cholesterol checking
Time frame: A survey response taken at the opportunistic screening.(1 = Yes-diabetes checking, 0 = No)
Self-reported diabetes checking
Time frame: A survey response taken at the opportunistic screening.(1 = Yes-attends regular checkups, 0 = No)
Self-reported attends regular physical check-ups
Time frame: A survey response taken at the opportunistic screening.(1 = Yes-consumes alcohol, 0 = No)
Self-reported uses alcohol
Time frame: A survey response taken at the opportunistic screening.(1 = Yes-smokes, 0 = No)
Self-reported smoking
Kelly Ann Schmidtke
Other
Behaviorally Enhanced Messages to Increase Medical Check-ups
Acronym: BEM-IMC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06743191
Behavior, Cardiovascular Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT06195839
Adherence, Patient, Behavior
Bastrop, Louisiana, United States
View Trial DetailsNCT03970590
Behavior, Cardiovascular Diseases
Chicago, Illinois, United States
View Trial DetailsNCT03875768
Behavior, Cardiovascular Diseases
Durham, North Carolina, United States
View Trial Details